MindBio Therapeutics Corp.
MBQIF
$0.60
-$0.01-1.64%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -415.60K | -130.70K |
| Total Revenue | -- | -- | -- | -415.60K | -130.70K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -415.60K | -130.70K |
| SG&A Expenses | 3.44M | 1.94M | 1.20M | 265.30K | 340.90K |
| Depreciation & Amortization | -56.60K | 1.20K | 1.00K | -600.00 | 25.90K |
| Other Operating Expenses | 17.10K | 17.10K | 17.80K | 17.80K | 17.80K |
| Total Operating Expenses | 3.40M | 1.96M | 1.22M | 282.50K | 384.50K |
| Operating Income | -3.40M | -1.96M | -1.22M | -698.10K | -515.20K |
| Income Before Tax | -3.89M | -2.55M | -1.79M | -1.04M | -401.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.89 | -2.55 | -1.79 | -1.04 | -0.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.30K | 0.00 | -100.00 | 3.20K | 2.40K |
| Net Income | -3.89M | -2.55M | -1.79M | -1.04M | -398.70K |
| EBIT | -3.40M | -1.96M | -1.22M | -698.10K | -515.20K |
| EBITDA | -1.83M | -1.93M | -1.14M | -168.40K | 40.90K |
| EPS Basic | -4.64 | -3.56 | -2.75 | -2.74 | -0.83 |
| Normalized Basic EPS | -2.17 | -1.50 | -1.00 | -0.80 | -0.52 |
| EPS Diluted | -4.64 | -3.56 | -2.75 | -2.74 | -0.83 |
| Normalized Diluted EPS | -1.75 | -1.50 | -1.00 | -0.80 | -0.52 |
| Average Basic Shares Outstanding | 3.71M | 128.68M | 128.10M | 127.25M | 127.25M |
| Average Diluted Shares Outstanding | 6.27M | 128.68M | 128.10M | 127.25M | 127.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |